Expanded Access Type: Intermediate-size Population

"Expanded access type: intermediate-size population" allows more than one patient access to a medicine or biological product that has not been approved by the Food and Drug Administration. This type of expanded access is used when multiple patients with the same disease or condition seek access to a specific unapproved medicine or biological product. (CTG) "